Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Reply Ob/Gyn & Fertility
- ·The full record, as it builds
Funding rounds
No funding rounds for Reply Ob/Gyn & Fertility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Reply Ob/Gyn & Fertility
Operator of a restorative reproductive medicine clinic intended to help patients understand, optimize and restore their natural fertility. The company offers a diagnostic-heavy, restorative approach that identifies underlying medical causes of infertility rather than bypassing them with IVF, enabling customers to achieve pregnancy naturally, at a lower cost and with improved overall reproductive health.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2015
- Employees
- 15
- Website
- replyfertility.com/
- Ownership
- Privately Held (backing)
Reply Ob/Gyn & Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Reply Ob/Gyn & Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Reply Ob/Gyn & Fertility in its N-PORT filings yet. We sweep new filings monthly.